Neovacs Quote - ALNEV

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.096

Bid

0.0909

Offer

0.0965

Volume

52,470

0.082 Day's Range 0.10

0.0001 52 Week Range 3.15

Market Cap

29.819k

Previous Close

0.0856

Open

0.082

Last Trade

407

0.096

Last Trade Time

23:25:35

Financial Volume

VWAP

Average Volume (3m)

1,012,835

Shares Outstanding

310,613

Dividend Yield

PE Ratio

-1,031,704.30

Earnings Per Share (EPS)

-28.15

Revenue

534k

Net Profit

-8.74M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.neovacs.com

Headquarters

Suresnes, Hauts-de-seine, Fra

Founded

Neovacs is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker ALNEV. The last closing price for Neovacs was 0.09 €. Over the last year, Neovacs shares have traded in a share price range of 0.0001 € to 3.15 €.

Neovacs currently has 310,613 shares in issue. The market capitalisation of Neovacs is 26,588.47 € . Neovacs has a price to earnings ratio (PE ratio) of -1031704.30.

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS COMMUNIQUE DE PRESSE ·...

NEOVACS :

NEOVACS : COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE L’OUVERTURE D’UNE PROCÉDURE DE REDRESSEMENT...

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Paris et...

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ...

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019 Paris et Boston, le 30 octobre 2019 – 17 : 45 CET - NÉOVACS (Euronext Paris :...

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019 COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE SES...

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.034	-26.1538461538	0.13	0.13	0.076	176492	0.09562962	DE
4	-0.2914	-75.219411461	0.3874	0.4305	0.076	142722	0.13789919	DE
12	0.0957	31900	0.0003	3.15	0.0003	1012835	0.013214	DE
26	0.0943	5547.05882353	0.0017	3.15	0.0001	23849066	0.00072902	DE
52	-1.304	-93.1428571429	1.4	3.15	0.0001	14030409	0.00192434	DE
156	-1.324	-93.2394366197	1.42	3.2	0.0001	21611094	0.00279118	DE
260	0.038	65.5172413793	0.058	4.399	0.0001	64197625	0.00695445	DE

ALNEV - Frequently Asked Questions (FAQ)

What is the current Neovacs share price?

The current share price of Neovacs is 0.096 €

How many Neovacs shares are in issue?

Neovacs has 310,613 shares in issue

What is the market cap of Neovacs?

The market capitalisation of Neovacs is EUR 26.59k

What is the 1 year trading range for Neovacs share price?

Neovacs has traded in the range of 0.0001 € to 3.15 € during the past year

What is the PE ratio of Neovacs?

The price to earnings ratio of Neovacs is -1.03M

What is the cash to sales ratio of Neovacs?

The cash to sales ratio of Neovacs is 16.89M

What is the reporting currency for Neovacs?

Neovacs reports financial results in EUR

What is the latest annual turnover for Neovacs?

The latest annual turnover of Neovacs is EUR 534k

What is the latest annual profit for Neovacs?

The latest annual profit of Neovacs is EUR -8.74M

What is the registered address of Neovacs?

The registered address for Neovacs is 14, RUE DE LA REPUBLIQUE, SURESNES, HAUTS-DE-SEINE, 92150

What is the Neovacs website address?

The website address for Neovacs is www.neovacs.com

Which industry sector does Neovacs operate in?

Neovacs operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLWEYWeya	0.0195 € (30.00%)	15k
MLACTActivium Group	1.33 € (16.67%)	100
ALNMRNamR SA	0.446 € (16.45%)	103.96k
VTRVitura	6.45 € (13.16%)	1.07k
ALNEVNeovacs	0.096 € (12.15%)	52.47k
LUDSLucibel DS	0.0006 € (-64.71%)	156.98k
ALSRSSirius Media	0.0155 € (-18.42%)	14.7M
ALDVAlliance Developpement Capital Siic	0.0605 € (-17.69%)	98.67k
WLNWorldline	6.192 € (-16.53%)	4.3M
MLSEQSequa Petroleum NV	0.0085 € (-15.00%)	4k
ATOAtos SE	0.0032 € (3.23%)	350.43M
ALVERVergnet	0.0004 € (0.00%)	82.07M
BCPBanco Comercial Portugues SA	0.5814 € (1.47%)	49.87M
ALHPIHopium SA	0.0025 € (-13.79%)	28.56M
ALCYBCybergun	0.0002 € (0.00%)	16.75M